Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice

Fausto Chiazza, Aurélie Couturier-Maillard, Elisa Benetti, Raffaella Mastrocola, Debora Nigro, Juan C. Cutrin, Loredana Serpe, Manuela Aragno, Roberto Fantozzi, Bernard Ryffel, Christoph Thiemermann, Massimo Collino

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Although the molecular links underlying the causative relationship between chronic low-grade inflammation and insulin resistance are not completely understood, compelling evidence suggests a pivotal role of the nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain containing 3 (NLRP3) inflammasome. Here we tested the hypothesis that either a selective pharmacological inhibition or a genetic downregulation of the NLRP3 inflammasome results in reduction of the diet-induced metabolic alterations. Male C57/BL6 wild-type mice and NLRP3-/- littermates were fed control diet or high-fat, high-fructose diet (HD). A subgroup of HD-fed wild-type mice was treated with the NLRP3 inflammasome inhibitor BAY 11-7082 (3 mg/kg intraperitoneally [IP]). HD feeding increased plasma and hepatic lipids and impaired glucose homeostasis and renal function. Renal and hepatic injury was associated with robust increases in profibrogenic markers, while only minimal fibrosis was recorded. None of these metabolic abnormalities were detected in HD-fed NLRP3-/- mice, and they were dramatically reduced in HD-mice treated with the NLRP3 inflammasome inhibitor. BAY 11-7082 also attenuated the diet-induced increase in NLRP3 inflammasome expression, resulting in inhibition of caspase-1 activation and interleukin (IL)-1β and IL-18 production (in liver and kidney). Interestingly, BAY 11-7082, but not gene silencing, inhibited nuclear factor (NF)-κB nuclear translocation. Overall, these results demonstrate that the selective pharmacological modulation of the NLRP3 inflammasome attenuates the metabolic abnormalities and the related organ injury/dysfunction caused by chronic exposure to HD, with effects similar to those obtained by NLRP3 gene silencing.

Lingua originaleInglese
pagine (da-a)1025-1037
Numero di pagine13
RivistaMolecular Medicine
Volume21
DOI
Stato di pubblicazionePubblicato - 23 nov 2015
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice'. Insieme formano una fingerprint unica.

Cita questo